Endocrinology Vol. 141, No. 11 4091-4099
Copyright © 2000 by The Endocrine Society
Characterization of Purinergic Receptors and Receptor-Channels Expressed in Anterior Pituitary Cells
Taka-aki Koshimizu,
Melanija Tomi
,
Anderson On-Lam Wong,
Dragoslava Zivadinovic and
Stanko S. Stojilkovic
Endocrinology and Reproduction Research Branch, National Institute
of Child Health and Human Development, National Institutes of Health,
Bethesda, Maryland 20892-4510
Address all correspondence and requests for reprints to: Dr. Stanko Stojilkovic, Section on Cellular Signaling, ERRB/NICHD, Building 49, Room 6A-36, 49 Convent Drive, Bethesda, Maryland 20892-4510. E-mail: stankos{at}helix.nih.gov
 |
Abstract
|
|---|
Purinergic G protein-coupled receptors (P2YR) and ion-conducting
receptor-channels (P2XR) are present in the pituitary. However, their
identification, expression within pituitary cell subpopulations, and
the ability to elevate intracellular Ca2+ concentration
([Ca2+]i) in response to ATP stimulation were
incompletely characterized. Here we show that mixed populations of rat
anterior pituitary cells express messenger RNA transcripts for
P2Y2R, P2X2aR, P2X2bR,
P2X3R, P2X4R, and P2X7R. The
transcripts and functional P2Y2R were identified in
lactotrophs and GH3 cells, but not in somatotrophs and gonadotrophs,
and their activation by ATP led to an extracellular
Ca2+-independent rise in [Ca2+]i
in about 40% of cells tested. Lactotrophs and GH3 cells, but not
somatotrophs, also express transcripts for P2X7R,
P2X3R, and P2X4R. Functional P2X7R
were identified in 74% of lactotrophs, whereas 50% of these cells
expressed P2X3R and 33% expressed P2X4R.
Coexpression of these receptor subtypes in single lactotrophs was
frequently observed. Purified somatotrophs expressed transcripts for
P2X2aR and P2X2bR, and functional receptors
were identified in somatotrophs and gonadotrophs, but not in
lactotrophs. Consistent with the cell-specific expression of
transcripts for P2X2R and P2X3R, the expression
of their functional heteromers was not evident in pituitary cells.
Receptors differed in their capacities to elevate and sustain
Ca2+ influx-dependent rise in
[Ca2+]i during the prolonged ATP stimulation.
These results indicate that the purinergic system of anterior pituitary
is extremely complex and provides an effective mechanism for generating
a cell- and receptor-specific Ca2+ signaling pattern in
response to a common agonist.
 |
Introduction
|
|---|
PURINERGIC receptors are operative in a
variety of tissues, including the pituitary gland (1).
G protein-coupled adenosine receptors (ARs) and adenosine
nucleo-tide-controlled receptors (P2YRs) and receptor-channels
(P2XRs) are expressed in the pituitary. Adenosine 5'-triphosphate
(ATP), the common and native agonist for all P2XRs and P2YRs, is
secreted by anterior pituitary cells (2, 3) and the
biological actions of ATP are terminated by ectonucleotidases
(2). These enzymes degrade extracellular ATP in a
sequential manner to adenosine, thereby activating ARs. The presence of
phospholipase C-coupled P2YR was initially observed in a mixed
population of sheep pituitary cells (4, 5). Single cell
Ca2+ measurements have shown that activation of
these receptors by ATP in rat pituitary cells is associated with an
elevation in the intracellular Ca2+
concentrations ([Ca2+]i)
derived from intracellular and extracellular sources
(6, 7, 8). Molecular cloning and functional characterization
of rat P2YRs in the pituitary revealed the presence of
P2Y2R subtype with the pharmacological profile
resembling the one observed in primary cultures of sheep pituitary
cells (9). Pharmacological studies have also suggested the
presence of P2XRs in pituitary cells (3, 10). The
messenger RNAs (mRNAs) for P2X2aR and its
spliced form, P2X2bR, in pituitary cells have
been identified recently (11, 12). Cultured and
immortalized pituitary cells also express
A1-subtype of adenosine receptors, which are
negatively coupled to adenylyl cyclase pathway. Receptor-mediated
suppression of cAMP production together with the activation of inward
rectifier potassium channels accounts for the inhibition of spontaneous
electrical activity and PRL release (13, 14).
The presence of all three types of purinergic receptors in
anterior pituitary is consistent with a view that ATP plays an
important role in the control of Ca2+-signaling
and secretion in anterior pituitary. However, it has not been clarified
as to which subtypes of P2 receptors are expressed and operative in the
pituitary, nor the cell specificity in the expression/coexpression of
these receptors. The focus in this study is on expression,
distribution, and Ca2+ signaling function of
P2YRs and P2XRs within three major subpopulations of secretory anterior
pituitary cells, including lactotrophs, gonadotrophs, and somatotrophs.
We screened the expression of all eight known P2XRs in cultured and
immortalized pituitary cells. To help with the identification of
receptor subtypes within these pituitary cells, we also expressed the
P2XRs in GT1 hypothalamic neurons, which have a set of plasma membrane
channels highly comparable to that of anterior pituitary cells
(15, 16), but do not express P2YRs and P2XRs
(12). The pharmacological and
Ca2+-signaling profiles of recombinant channels
were compared with those observed in secretory anterior pituitary
cells. The results of these investigations revealed an unusual
complexity in the expression pattern and
Ca2+-signaling functions of these receptors and
channels in the pituitary, especially in the lactotrophs.
 |
Materials and Methods
|
|---|
Cell cultures and transfection
Experiments were performed on anterior pituitary cells from
adult female Sprague Dawley rats from Taconic Farms, Inc.
(Germantown, NY), as well as on immortalized GH3 pituitary cells and
GT1 hypothalamic neurons. Pituitary cells were dispersed as previously
described (12) and cultured in medium 199 containing
Earles salts, sodium bicarbonate, 10% horse serum, and antibiotics.
GH3 and GT1 cells were cultured in DMEM medium containing 10% FCS
(Life Technologies, Inc., Rockville, MD). Procedures for
transient transfection in GT1 cells were performed as described
(17) with minor modifications. Briefly, cells were plated
on 35 mm coverslips coated with poly-L-lysine at a density
of 7.5 x 104 cell per 35 mm dish and
allowed to grow for 24 h. On the day of transfection, a total
amount of 1.2 µg of expression constructs encoding P2XRs was mixed
with 8 µl of cationic lipid Lipofectamine in a 1.2 ml of Opti-MEM
medium (Life Technologies, Inc.), for 15 min at ambient
temperature. The DNA mixture was then applied to cells for 3 h and
replaced by normal culture medium. The cells were subjected to
experiments 48 h after the transfection.
Cell purification
Separation of gonadotroph-, somatotroph-, and
lactotroph-enriched populations was performed according to the size and
density of pituitary cells, using the Eppendorf Cell
Separation System. The one-liter disc-shaped chamber was filled from
the bottom opening with about 900 ml of 2% to 4% Ficoll
continuous gradient solution and then completed with 10% Ficoll
solution. Dispersed cells (100 x 106) were
suspended in 50 ml of 1% Ficoll solution and loaded into the chamber
from the top opening. After adding 30 ml of separation medium on the
top, the chamber was oriented to the horizontal position and was
allowed to sediment at unit gravity for 2 h. The chamber was then
reoriented to the inclined position and 15 fractions were collected
from the bottom opening. Cells were washed, counted, and
105 cells from the unfractionated sample and from
each separated fraction were suspended in 10 mM sodium
carbonate, sonicated, and kept frozen at -20 C. Their hormonal
contents were estimated by RIAs for rat LH, FSH, TSH, ACTH, PRL, and
GH, which were done using the kits provided by Dr. Parlow and the
National Hormone Pituitary Program. The highest concentrations of LH,
TSH, GH, ACTH, and PRL were respectively found in fractions 1, 4, 8,
10, and 14. Estimated by the reverse hemolytic plaque assay, the
percentage of purified cells was: 82% for LH-secreting cells, 68% for
GH-secreting cells, and 85% for PRL-secreting cells. Purification of
somatotrophs and lactotrophs was also done by a two-stage Percoll
discontinuous density gradient centrifugation (18). Using
the immunohistochemical staining approach, the purity of the enriched
somatotroph and lactotroph fractions was estimated to be 92% and 64%,
respectively.
Measurements of intracellular calcium ion concentration
For [Ca2+]i
measurements, cells were incubated in Krebs-Ringer buffer, supplemented
with 2 µM fura-2 AM, at 37 C for 60 min. Coverslips with
cells were washed with this buffer and mounted on the stage of an
Axiovert 135 microscope (Carl Zeiss, Oberkochen, Germany)
attached to the Attofluor Digital Fluorescence Microscopy System (Atto
Instruments, Rockville, MD). Cells were examined under a 40x oil
immersion objective during exposure to alternating 340 and 380 nm light
beams, and the intensity of light emission at 520 nm was measured. The
ratio of light intensities,
F340/F380, which reflects
changes in Ca2+ concentration, was followed in
several single cells simultaneously at room temperature.
RT-PCR analysis of purinergic receptors and channels
Total RNA was isolated from mixed pituitary cells, or enriched
somatotrophs and lactotrophs using TRIZOL reagent (Life Technologies, Inc.). First strand complementary DNA (cDNA) was
then synthesized using a Superscript preamplification system
(Life Technologies, Inc.). After RT using Superscript II
RT and removal of RNA templates by RNase H digestion, a 5 µl-aliquot
of first strand cDNA was used in subsequent PCR reactions. Primers for
the P2XRs used in experiments are described in Ref (19).
The P2Y2 specific primers corresponded to the rat
P2Y2R sequence: nucleotides 404 to 424 for the
sense primer (5'-AACGGACGCTGAGCATCCAAG-3') and 1611 to 1631 for the
antisense primer (5'-TGAACTGACACCTGACTGAGC-3'). PCR conditions
consisted of an initial denaturation step of 2 min at 94 C, followed by
2025 cycles of denaturation at 94 C for 1 min, annealing at 60 C for
1 min, and extension at 72 C for 2 min. All PCRs were concluded with a
final extension step of 10 min at 72 C. PCR samples were then
size-fractionated in 1% agarose gel and visualized with ethidium
bromide staining. To check for the integrity of RNA preparation, RT-PCR
of GAPDH was also conducted as an internal control using primers
GAPDH.S (5'-GGCATCCTGGGCTACACTG-3') and GAPDH.AS
(5'-TGAGGTCCACCACCCTGTT-3') according to the PCR conditions reported
previously (20). In these experiments, plasmids with the
coding sequence of P2YR or P2XR cDNAs were used as the positive control
for the respective PCRs.
 |
Results
|
|---|
Distribution of P2YRs and P2XRs within the anterior pituitary
cells
To characterize the distribution of P2YRs and P2XRs within the
different cell types, ATP-induced
[Ca2+]i responses were
analyzed in enriched subpopulations of secretory anterior pituitary
cells. As discussed in Materials and Methods, purification
of cells by Ficoll gradient procedure leads to 15 fractions of cells.
Measurements of hormone contents in these fractions revealed that the
first 3 fractions predominantly contained LH, fractions 35 TSH,
fractions 510 GH, fractions 811 ACTH, and fractions 1115 PRL. As
shown in Fig. 1
, the rise in
[Ca2+]i in response to
GnRH was highly specific for gonadotrophs, as estimated by the
parallelism between the profiles of GnRH responsive cells (B) and LH
content in these cells (C), and by their inability to respond to TRH
(E). On the other hand, there was a close correlation between PRL
content profile (F) with that of TRH-responsive cells identified based
on single cell Ca2+ measurements (E). The
TSH-containing fractions 35 also responded to TRH (E). A small
fraction of unidentified cells (12%) from fraction 9 responded to
both TRH and GnRH (see also Ref. 21). Thus, these isolation procedures
provide an effective system to enrich gonadotrophs and lactotrophs, to
separate the TRH-sensitive thyrotrophs and lactotrophs, and to identify
single gonadotrophs and lactotrophs with respect to GnRH- and
TRH-induced [Ca2+]i
responses.

View larger version (26K):
[in this window]
[in a new window]
|
Figure 1. Distribution of purinergic receptors and
receptor-channels within the subpopulations of anterior pituitary
cells. Dispersed cells were separated by Ficoll gradient into 15
fractions as described in Materials and Methods. A and
B, Percentage of cells responding to ATP (A) and ATP + GnRH (B), both
when bathed in Ca2+-containing medium. C, LH content in
different fractions (normalized values). D and E, Percentage of cells
responding to ATP (D) and TRH (E) when bathed in Ca2+-
deficient medium. F, PRL content in different fractions (normalized
values). In A, B, D, and E, number of cells analyzed for
[Ca2+]i response per fraction varied between
25 and 62. In C and F, 105 cells were dialyzed immediately
after separation to measure LH and PRL cell content.
|
|
In Ca2+-containing medium, 100
µM ATP increased
[Ca2+]i in 5090% of
the cells in different fractions, suggesting that purinergic receptors
are native to all subpopulations of cells (Fig. 1A
). The majority of
GnRH-responsive cells also responded to ATP when bathed in
Ca2+-containing medium (B), and only 12% of
these cells responded to ATP when bathed in
Ca2+-deficient medium (D). In lactotroph
fractions of pituitary cells, however, ATP elevated
[Ca2+]i in about 40% of
cells in Ca2+-deficient medium (D) and in
8090% of cells in Ca2+-containing medium (A).
A group of unidentified cells elutriated with somatotroph/corticotroph
fractions also responded to ATP with an extracellular
Ca2+-independent rise in
[Ca2+]i (fractions
510). These results indicate that
Ca2+-mobilizing P2YRs are predominantly expressed
in lactotrophs, whereas all subpopulations of anterior pituitary cells
expressed P2XRs capable of facilitating Ca2+
influx.
Characterization of pituitary P2YRs
The pharmacological profile of P2YRs expressed in lactotrophs is
shown in Fig. 2
. In addition to ATP,
these receptors also responded to uridine triphosphate (UTP), a
specific agonist for P2Y2R and
P2Y4R, and
adenosine-5'-O-(3-thio-triphosphate) (ATP-
-S) when bathed in
Ca2+-deficient medium (Fig. 2A
). The relative
potency of ATP agonists for these receptors was ATP > UTP >
ATP-
-S. We have also examined the effects of
3'-O-(4-benzoyl)benzoyl-ATP (BzATP), a relatively specific
agonist for P2X7R (22), on
[Ca2+]i response in
lactotrophs bathed in Ca2+-deficient medium. As
shown in Fig. 2A
, BzATP was unable to initiate
Ca2+ signaling in lactotrophs. Several other ATP
analogs, including
,ß-methylene ATP (
,ß-meATP; Fig. 2A
) and
2-methylthio-ATP (2-MeS-ATP; not shown) were also ineffective in
generating Ca2+ signals in lactotrophs bathed in
Ca2+-deficient medium. Such a pharmacological
profile of [Ca2+]i
responses was typical for all responding cells, suggesting that these
cells express P2Y2R subtype. In accordance with
the results of pharmacological characterization, RT-PCR using
P2Y2R primers also detected a PCR fragment with
the expected size of P2Y2R in enriched
lactotrophs. This specific message was also identified in immortalized
GH3 cells (Fig. 2B
).

View larger version (32K):
[in this window]
[in a new window]
|
Figure 2. Characterization of P2YR expressed in lactotrophs.
A, Pattern of [Ca2+]i response in purified
lactotrophs. Arrows indicate the moment of agonist
application. The final concentration of ATP and its analogs was 100
µM. At the end of each experiment, 100 nM TRH
was added. Experiments were performed in Ca2+-deficient
medium. About 40% of lactotrophs responded to ATP in such conditions.
B, RT-PCR analysis of P2YR mRNA expression in enriched lactotrophs and
GH3 cells (left panel). PCR was conducted using primers
specific for rat P2Y2R. PCR products were then separated in
1% agarose gel and visualized with ethidium bromide. RT-PCR of
glyceraldehyde phosphate dehydrogenase (GAPDH, right
panel) was performed to monitor the quality of RNA preparation.
Total RNA isolated from the rat brain was used as the positive control.
In the case of "no template" control, water was substituted for the
first strand cDNA sample in PCR reaction.
|
|
Expression of P2XR transcripts in anterior pituitary cells
Molecular identification of P2XRs expressed in anterior pituitary
cells was also obtained by RT-PCR analysis. Using specific rat
P2X2R primers, which covered the entire open
reading frame of P2XR cDNA sequence, two sizes of PCR products of about
1.6 kb and 1.4 kb long were detected in mixed populations of pituitary
cells (Fig. 3A
, lane 1). As described in
(12), these products corresponded to
P2X2aR and its spliced form,
P2X2bR, and their presence in the mixed
population of pituitary cells was confirmed by specific primers. The
mRNAs for these channels were observed in somatotrophs purified by
two-stage Percoll discontinuous density gradient centrifugation (Fig. 3C
, lane 2).

View larger version (37K):
[in this window]
[in a new window]
|
Figure 3. Expression of P2XRs in pituitary cells. A,
Detection of P2XRs in mixed population of anterior pituitary cells
(lane 1) and immortalized GH3 cells (lane 4). B, Expression of
P2X3R, P2X4R, and P2X7R mRNA in
enriched somatotrophs (lane 2) and lactotrophs (lane 4). C, Expression
of P2X2R mRNA in enriched somatotrophs (lane 2). Plasmids
containing the coding sequence of the respective P2XR cDNAs were used
as positive controls (A, lanes 2 and 5; B and C, lane 1). For negative
controls, PCR was conducted using first strand cDNA samples without RT
(A, lanes 3 and 6; B, lanes 3 and 5; C, lane 3). In the case of "no
template" control, water was substituted for first strand cDNA sample
in PCR reactions (B, lane 6; C, lane 4). DNA markers are shown in lanes
7 and 8 (B) and 5 and 6 (C). Primer sequences are described in Ref.
19 . A 10 µl-aliquot of PCR products was analyzed in 1%
agarose gel containing ethidium bromide. GAPDH primers were used as an
internal control to monitor the quality of RNA preparation.
|
|
In addition to P2X2R transcripts, mixed
anterior pituitary cells also expressed transcripts for
P2X3R, P2X4R, and
P2X7R (Fig. 3A
, lane 1). Immortalized GH3
pituitary cells also expressed transcripts for
P2X3R, P2X4R, and
P2X7R, but not P2X2aR and
P2X2bR (Fig. 3A
, lane 4). In parallel to GH3
transcript profile, the messages for P2X3R,
P2X4R, and P2X7R were found
in purified lactotrophs (Fig. 3B
, lane 4), but not in somatotrophs
(lane 2). Finally, the transcripts for P2X1R,
P2X5R, and P2X6R were not
observed in mixed pituitary cells (Fig. 3A
, lane 1) and GH3 cells (Fig. 3A
, lane 4).
Calcium signaling by recombinant channels
To help identify functional P2XR subtypes present in anterior
pituitary cells, the recombinant channels were expressed in GT1 neurons
and their pharmacological and
[Ca2+]i signaling
profiles were compared with those observed in lactotrophs,
somatotrophs, and gonadotrophs. As shown in Fig. 4
, GT1 cells expressing homomeric
P2X3R responded to
ß-methylene ATP
(
ß-meATP) with a small amplitude and transient rise in
[Ca2+]i. In accord with
the literature data (19, 23, 24), the heteromeric
P2X2R + P2X3R channels also
responded to this agonist (Fig. 4A
). However, the amplitude of
ß-meATP-induced
[Ca2+]i responses in
cells expressing P2X2R +
P2X3R was higher compared with that observed in
P2X3R-expressing cells (Fig. 4A
vs.
4B). Cells expressing P2X2aR,
P2X2bR, P2X4R, and
P2X7R were insensitive to
ß-meATP (Fig. 4
, CF). These results indicate that
ß-meATP can be used in
[Ca2+]i measurements, as
in current measurements (23) as a highly selective agonist
for the identification of functional P2X3R
homomers and P2X2R + P2X3R
heteromers.
Another agonist, 3'-O-(4-benzoyl)benzoyl-ATP (BzATP)
was able to elevate
[Ca2+]i in cells
expressing P2X7R, P2X2aR,
and P2X2bR, whereas P2X3R-
and P2X4R-expressing cells were practically
insensitive to this agonist (Fig. 5A
). In
P2X7R-expressing cells, addition of 100
µM ATP in the presence of 100
µM BzATP was ineffective (Fig. 5A
, bottom
trace), whereas in all P2X2aR and
P2X2bR-expressing cells ATP was able to further
elevate [Ca2+]i (two top
traces). This suggests that P2X7R is more
sensitive to BzATP, contrary to P2X2aR and
P2X2bR, which are more sensitive to ATP.
Consistent with this, BzATP induced an additional rise in
[Ca2+]i in
P2X7R-expressing cells already stimulated with
ATP, 2-MeS-ATP, or ATP-
-S (Fig. 5B
, right traces) but was
ineffective in P2X2aR-expressing cells stimulated
with these agonists (Fig. 5B
, left traces). Such
pharmacological profiles of P2X2R and
P2X7R provide an effective tool to identify cells
expressing these two channels.

View larger version (30K):
[in this window]
[in a new window]
|
Figure 5. Effects of BzATP on Ca2+ influx in GT1
neurons transiently expressing the recombinant P2XRs. A, Effects of
BzATP and ATP on [Ca2+]i in cells expressing
different P2XRs. ATP was added in the presence of BzATP. B, Comparison
of the effects of BzATP vs. other ATP analogs on
[Ca2+]i in cells expressing
P2X2aR (left traces) and P2X7R
(right traces).
|
|
The BzATP-insensitivity of P2X4R (Fig. 5A
)
is a useful but not sufficient tool in a search for cells expressing
these channels. However, only two cloned channels,
P2X4R and P2X6R, are
insensitive to suramin, a P2XR antagonist (25). As shown
in Fig. 6A
, ATP-induced
[Ca2+]i response in
P2X4R-expressing cells was not affected by the
addition of 200 µM suramin for 3 min before the
application of ATP. Because the message for P2X6R
was not observed in pituitary cells (Fig. 3
), the insensitivity of
P2X4R channels to suramin was employed in a
search for their expression in pituitary cells.

View larger version (13K):
[in this window]
[in a new window]
|
Figure 6. Characterization of P2X4R in GT1
neurons and lactotrophs. A, Suramin-insensitivity of recombinant
P2X4R expressed in GT1 neurons. The tracings shown are
averaged data from 20 records. B, Suramin-insensitivity of ATP-induced
[Ca2+]i response in a fraction of
lactotrophs.
|
|
Characterization of P2XR expressed in pituitary cells
In a mixed population of anterior pituitary cells,
ß-meATP,
the specific agonist for P2X3R and
P2X2R + P2X3R, was able to
induce rise in [Ca2+]i
only in TRH-sensitive cells. A fraction of lactotrophs, but not
gonadotrophs and somatotrophs, also responded to
ß-meATP with a
rise in [Ca2+]i, the
pattern of which was highly comparable to that observed in GT1 neurons
expressing homomeric P2X3R (Fig. 7A
vs. 4B). None of the
ß-meATP-sensitive cells generated
[Ca2+]i signals with the
amplitude and duration comparable to that observed in cells bearing
heteromeric P2X2R + P2X3R.
This is consistent with the absence of P2X2R
transcripts in immortalized GH3 cells (Fig. 3A
) and
P2X3R transcripts in purified somatotrophs (Fig. 3B
), further suggesting that lactotrophs only express
P2X3R homomers. Table 1
illustrates that about 50% of
lactotrophs express these channels.

View larger version (33K):
[in this window]
[in a new window]
|
Figure 7. Pharmacological characterization of P2XR and P2YR
in lactotrophs. A, Characterization of , ß-meATP- sensitive
P2X3R in lactotrophs. Top trace, Lactotroph
responding to , ß-meATP, the specific agonist for
P2X3R, but not to ATP. Bottom traces, Cells
responding to both , ß-meATP and ATP or BzATP, which were added in
the presence of , ß-meATP. B, Characterization of
P2X7R expressed in lactotrophs by comparing the potency of
ATP and its analogs in promoting Ca2+ influx. C,
Coexpression of BzATP-sensitive P2X7R and BzATP-insensitive
P2Y2R in lactotrophs.
|
|
On the other hand, BzATP, an agonist that activates
P2X7R and P2X2R, induced
rises in [Ca2+]i in a
majority of lactotrophs, somatotrophs, and gonadotrophs. About 75% of
lactotrophs (Table 1
) responded to BzATP with the nondesensitizing
[Ca2+]i response,
typically observed in P2X7R-expressing cells.
Consistent with this conclusion, addition of ATP, ATP-
-S, and
2-MeS-ATP in the presence of BzATP was ineffective in all lactotrophs
studied. Figure 7B
illustrates three such cells. In contrast to
lactotrophs, addition of ATP, ATP-
-S, and 2-MeS-ATP in the presence
of BzATP, induced further increase in
[Ca2+]i in somatotrophs
and gonadotrophs (Fig. 8
), indicating
that these cells express P2X2R. In accordance
with this, BzATP was unable to elevate
[Ca2+]i in the presence
of ATP, ATP-
-S, or 2-MeS-ATP (Fig. 8
, right tracings).
This pattern of response was observed in 84% of gonadotrophs, and 82%
of somatotrophs (Table 1
).

View larger version (39K):
[in this window]
[in a new window]
|
Figure 8. Pharmacological characterization of
P2X2R expressed in somatotrophs (left
traces) and gonadotrophs (right traces). In
somatotrophs, the traces shown are typical of those observed in
quiescent cells (top trace) and spontaneously active
cells (three bottom tracings). Arrows at
bottom illustrate the moment of drug application in all traces shown.
In gonadotrophs, the majority (about 80%) of cells were quiescent, and
tracings shown are representative from such cells.
|
|
Finally, in a fraction of lactotrophs (Table 1
), 100
µM ATP induced suramin-insensitive
[Ca2+]i response, the
pattern of which was highly comparable to that observed in GT1 neurons
expressing homomeric P2X4R. Figure 6B
illustrates
a cell responding to ATP in suramin-containing and -deficient medium.
Such a pattern of [Ca2+]i
response was observed in about 33% of lactotrophs (Table 1
). These
results indicate that somatotrophs and gonadotrophs exclusively express
P2X2R, whereas lactotrophs express
P2X3R, P2X4R, and
P2X7R, in addition to already characterized
P2Y2R (6).
The coexpression of P2XRs in single lactotrophs was frequently
observed. A fraction of cells expressing the
,ß-meATP-sensitive
P2X3R, also responded to the application of BzATP
and ATP with additional rise in
[Ca2+]i, presumably by
activating P2X7R (Fig. 7A
, two bottom
traces). Similarly, about 15% of lactotrophs responded to BzATP
with a nondesensitizing response and ATP with a spike response,
suggesting the expression of both P2X7R and
P2Y2R in the same cells (Fig. 7C
, upper
trace). Consistent with this, removal of extracellular
Ca2+ abolished BzATP-induced rise in
[Ca2+]i and the
subsequent addition of ATP in Ca2+-deficient
medium generated a typical Ca2+-mobilizing spike
response. Finally, ATP was able to induce a suramin-insensitive rise in
[Ca2+]i in a small
fraction of lactotrophs already stimulated with BzATP, the profile of
which was comparable to that observed in GT1 neurons expressing
P2X4R (not shown).
In addition to the variable agonist sensitivity, pituitary P2XRs
also differed with respect to their peak amplitude
[Ca2+]i responses and
temporal response patterns. As shown in Table 2
, the highest amplitude of
[Ca2+]i response was
observed in pituitary gonadotrophs and somatotrophs expressing
P2X2R. The peak amplitudes generated by
P2X7R in lactotrophs were somewhat smaller,
whereas the peak amplitude of
[Ca2+]i response in
lactotrophs expressing P2X3R and
P2X4R was about 40% of that observed in cells
expressing P2X2R. The native receptors also
desensitized with different rates: P2X3R >
P2X4R > P2X2R >
P2X7R (Table 2
).
 |
Discussion
|
|---|
Functional purinergic receptors and receptor-channels are present
in all subpopulations of pituitary cells, indicating that ATP acts as a
nonselective agonist in the control of pituitary functions
(10). However, the identification of receptor subtypes
expressed in the pituitary and the selectivity of their expression in
individual secretory cell types were incompletely characterized. Here
we have identified the P2XR and P2YR subtypes that are operative in
anterior pituitary and have characterized their expression in three
secretory cell types: gonadotrophs, somatotrophs, and lactotrophs. Our
RT-PCR results indicate that mixed pituitary cells express mRNA
transcripts for P2Y2R,
P2X2aR, and P2X2bR. In
addition to those transcripts that have been previously found in mixed
pituitary cells (9, 12), we have also identified
transcripts for P2X3R,
P2X4R, and P2X7R. The
transcripts for P2Y2R,
P2X3R, P2X4R, and
P2X7R were found in lactotrophs, but not in
somatotrophs, which exclusively express transcripts for
P2X2aR and P2X2bR. The
RT-PCR analysis of P2XRs in gonadotrophs was inconclusive, probably
because of the low number of cells obtained by our cell purification
procedures. Consistent with the results of RT-PCR analysis, single cell
[Ca2+]i measurements
indicate that lactotrophs express functional
P2Y2R, as well as P2X3R,
P2X4R, and P2X7R, whereas
somatotrophs express P2X2R. The extensive
pharmacological characterization of P2XRs in gonadotrophs also
indicates that these cells express exclusively
P2X2R subtypes.
When activated, these receptor-channels generate
[Ca2+]i signals of
different amplitude and duration. P2X3R generates
small amplitude [Ca2+]i
signals, which desensitize within 12 min. In contrast,
P2X7R generates high amplitude
[Ca2+]i signals that do
not desensitize during the prolonged agonist stimulation.
P2X2Rs expressed in gonadotrophs and somatotrophs
are able to generate high amplitude
[Ca2+]i signals, but they
desensitize gradually and lead to the attenuation of
Ca2+ signals to about 1020% of that observed
at the beginning of stimulation. In general, such pattern of
Ca2+ signals resembles those observed in GT1
neurons transiently expressing recombinant P2XRs. However, in the case
of P2X7R, there are differences between the peak
amplitude of [Ca2+]i
responses in pituitary cells vs. that of GT1 cells when
stimulated with BzATP, which may be result of overexpression of these
channels in host cells. The recombinant P2X2aR
also desensitizes incompletely in GT1 cells, but the time needed to
reach the steady-state signaling is prolonged when compared with the
native P2X2Rs expressed in pituitary cells. This
suggests that the mechanism of controlling Ca2+
influx through P2X2R is different between
pituitary cells and GT1 cells used in our expression studies.
The coexpression of P2X2R with
P2X3R provides an effective mechanism to control
Ca2+ influx through P2X2aR
(23, 24). Although the transcripts for
P2X3R are present in pituitary cells; however,
several lines of evidence argue against the existence of
P2X2aR + P2X3R heteromers
in pituitary cells. Purified lactotrophs and immortalized GH3 cells
expressed the transcripts for P2X3R, whereas the
transcripts for P2X2aR and
P2X2bR were identified in somatotrophs. In
parallel to that, functional P2X3R was identified
in lactotrophs, as well as in an unidentified cell type, but not in
gonadotrophs and somatotrophs. Finally, none of the
,ß-meATP-sensitive cells from mixed subpopulations exhibited the
pattern of Ca2+ signals generated by the
recombinant P2X2aR + P2X3R
heteromers. The cell specific expression of P2X2R
and P2X3R in anterior pituitary probably accounts
for the lack of coexpression of such heteromers.
On the other hand, we (12) and others (26, 27) reported recently that the control of
Ca2+ influx through P2X2R
can be achieved by the coexpression of P2X2aR and
P2X2bR. Depending on the assemble mode, such
heteromers can desensitize with variable rates (12). The
Ca2+-signaling profiles in pituitary cells
expressing P2X2R also resemble that of GT1 cells
cotransfected with equal amounts of transcripts for
P2X2aR and P2X2bR. Thus, it
is reasonable to speculate that the control of ATP-induced
[Ca2+]i signals in
gonadotrophs and somatotrophs is achieved by expressing
P2X2aR + P2X2bR
heteromers.
In contrast to P2X3R and
P2X2R, the native pituitary
P2X7R and its recombinant channels expressed in
GT1 cells do not exhibit an obvious desensitization. In the majority of
cell expressing P2X7R channels, ATP initially
induces opening of a channel selective for cations, including
Ca2+ (25). During the prolonged
agonist stimulation, P2X7R opens large pores
allowing permeation of larger molecules and permeabilization of cells
(22, 28). This activation step is dependent on the
presence of C-terminus of the receptor (22) and on the
environmental temperature (29). The physiological
significance of this action is still unknown. Because the increased
permeability results in larger ion fluxes and leakage of small
metabolites, it may cause cell swelling and vacuolization, leading to
cell death by necrosis and/or apoptosis (reviewed in Ref.
25). However, whether and to what extent
P2X7R is used in the control of cell death in
lactotrophs is still premature to discuss.
In conclusion, the results of these investigations indicate that
the specificity found in the Ca2+-signaling
responses induced by a common agonist is achieved by the capacity of
individual receptor subtypes to generate different amplitude and
kinetic patterns of Ca2+ responses and by the
selective expression of receptors within the pituitary cell
subpopulations. The ATP signaling pathway in somatotrophs and
gonadotrophs is relatively simple. The majority of these cells express
P2X2aR and P2X2bR, and
their coexpression provides an effective system for a rapid elevation
in [Ca2+]i, which is
followed by a sustained plateau Ca2+ response of
a much smaller amplitude. We were unable to observe any other P2X
receptor subtypes expressed in these cells. The most striking finding
shown here is the complexity of purinergic signaling system of
lactotrophs. These cells express three types of channels,
P2X3R, P2X4R, and
P2X7R, as well as the
Ca2+-mobilizing P2Y2R. The
identification of P2XRs expressed in thyrotrophs and corticotrophs
requires further studies. Pituitary P2X receptors can provide a wide
range of Ca2+ signaling patterns when expressed
individually or in combination. In this regard, the pituitary cells may
provide a model to study how multiple receptors when expressed in
excitable cells may generate different signaling in response to the
same endogenous ligand.
 |
Acknowledgments
|
|---|
We are thankful to Drs. Silvie Dufour, Mohamed A. Virmani, and
Antonio Martinez-Fuentes for help in establishing the purification
procedures for pituitary cells.
Received March 20, 2000.
 |
References
|
|---|
-
Brake AJ, Julius D 1996 Signaling by
extracellular nucleotides. Annu Rev Cell Dev Biol 12:519541[CrossRef][Medline]
-
Tomic M, Jobin RM, Vergara LA, Stojilkovic
SS 1996 Expression of purinergic receptor channels and their role
in calcium signaling and hormone release in pituitary gonadotrophs.
J Biol Chem 271:2120021208[Abstract/Free Full Text]
-
Chen Z-P, Kratzmeier M, Levy A, McArdle CA, Poch
A, Day A, Mukhopadhyay AK, Lightman SL 1995 Evidence for a role of
pituitary ATP receptors in the regulation of pituitary function. Proc
Natl Acad Sci USA 92:52195223[Abstract/Free Full Text]
-
Van Der Merwe PA, Wakefield IK, Fine J, Millar
RP, Davidson JS 1989 Extracellular adenosine triphosphate
activates phospholipase C and mobilizes intracellular calcium in
primary cultures of sheep anterior pituitary cells. FEBS Lett 243:333336[CrossRef][Medline]
-
Davidson JS, Wakefield IK, Sohnius U, Van Der
Merwe PA, Millar RP 1990 A novel extracellular nucleotide receptor
coupled to phosphoinositidase-C in pituitary cells. Endocrinology 126:8087[Abstract]
-
Carew MA, Wu M-L, Law GJ, Tseng Y-Z, Mason
WT 1994 Extracellular ATP activates calcium entry and mobilization
via P2XU-purinoceptors in rat lactotrophs. Cell Calcium 16:227235[CrossRef][Medline]
-
Chen Z-P, Levy A, McArdle CA, Lightman SL 1994 Pituitary ATP receptors: characterization and functional
localization to gonadotropes. Endocrinology 135:12801284[Abstract]
-
Chen Z-P, Kratzmeier M, Poch, Xu S, McArdle CA,
Levy A, Mukhopadhyay AK, Lightman SL 1996 Effects of extracellular
nucleotides in the pituitary: adenosine triphosphate receptor-mediated
intracellular responses in gonadotrope-derived
T31 cells.
Endocrinology 137:248256[Abstract]
-
Chen Z-P, Krull N, Xu L, Levy A, Lightman
SL 1996 Molecular cloning and functional characterization of a rat
pituitary G protein-coupled adenosine triphosphate (ATP) receptor.
Endocrinology 137:18331840[Abstract]
-
Villalobos C, Alonso-Torre SR, Nunez L,
Garcia-Sancho J 1997 Functional ATP receptors in rat anterior
pituitary cells. Am J Physiol 273:C1963C1971
-
Brake AJ, Wagenbach, MJ, Julius D 1994 New
structural motif for ligand-gated ion channels defined by an ionotropic
ATP receptor. Nature 371:519523[CrossRef][Medline]
-
Koshimizu T, Tomic M., Van Goor F, Stojilkovic
SS 1998 Functional role of alternative splicing in pituitary
P2X2 receptor-channel activation and
desensitization. Mol Endocrinol 12:901913[Abstract/Free Full Text]
-
Schettini G, Landolfi E, Meucci O, Florio T,
Grimaldi M, Ventra C. Marino A 1990 Adenosine and its analogue
(-)N6-R-phenyl-isopropyladenosine modulate anterior pituitary adenylate
cyclase activity and prolactin secretion in the rat. J Mol Endocrinol 5:6976[Abstract]
-
Mollard P, Guerineau N, Chiavaroli C, Schlegel W,
Cooper DM 1991 Adenosine A1 receptor-induced
inhibition of Ca2+ transients linked to action
potentials in clonal pituitary cells. Eur J Pharmacol 206:271277[CrossRef][Medline]
-
Van Goor F, Krsmanovic LZ, Catt KJ, Stojilkovic
SS 1999 Control of action potential-driven calcium influx in GT1
neurons by the activation status of sodium and calcium channels. Mol
Endocrinol 13:587603[Abstract/Free Full Text]
-
Van Goor F, Krsmanovic LZ, Catt KJ, Stojilkovic
SS 1999 Coordinate regulation of gonadotropin-releasing hormone
neruonal firing patterns by cytosolic calcium and store depletion. Proc
Natl Acad Sci USA 96:41014106[Abstract/Free Full Text]
-
Koshimizu T, Tomic M, Koshimizu M, Stojilkovic
SS 1998 Identification of amino acid residues contributing to
desensitization of the P2X2 receptor channel.
J Biol Chem 273:1285312857[Abstract/Free Full Text]
-
Lussier BT, French MB, Moor BC, Kraicer J 1991 Free intracellular Ca2+ concentration
([Ca2+]i and growth
hormone release from purified rat somatotrophs. Endocrinology 128:570582[Abstract]
-
Koshimizu T, Koshimizu M, Stojilkovic SS 1999 Contributions of the C-terminal domain to the control of P2X
receptor desensitization. J Biol Chem 274:3765137657[Abstract/Free Full Text]
-
Fort P, Rech J, Vie A., Piechaczyk M, Bonnieu A,
Jeanteur P, Blanchard J-M 1987 Regulation of c-fos gene expression
in hamster fibroblast: initiation and elongation of transcription and
mRNA degradation. Nucleic Acids Res 15:56575665[Abstract/Free Full Text]
-
Villalobos C, Nunez L, Frawley LS, Garcia-Sancho
J, Sanchez A 1997 Multi-responsiveness of single anterior
pituitary cells to hypothalamic-releasing hormones: a cellular basis
for paradoxical secretion. Proc Natl Acad Sci USA 94:1413214137[Abstract/Free Full Text]
-
Surprenant A, Rassendren F, Kawashima E, North
RA, Buell G 1996 The cytosolic P2XZ receptor for extracellular ATP
identified as a P2X receptor (P2X7). Science 272:735738[Abstract]
-
Lewis C, Neidhart S, Holy C, North RA, Buell G,
Surprenant A 1995 Coexpression of P2X2 and
P2X3 receptor subunits can account for ATP-gated
currents in sensory neurons. Nature 377:432435[CrossRef][Medline]
-
Radford KM, Virginio C, Surprenant A, North A.
Kawashima E 1997 Baculovirus expression provides direct evidence
for heteromeric assembly of P2X2 and
P2X3 receptors. J Neurosci 17:65296533[Abstract/Free Full Text]
-
Ralevic V, Burnstock G 1998 Receptors for
purines and pyrimidines. Pharmacol Rev 50:413492[Abstract/Free Full Text]
-
Brandle U, Spielmanns P, Osteroth R, Sim J,
Surprenant A. Buell G, Ruppersberg JP, Plinkert PK, Zenner H-P,
Glowatski E 1997 Desensitization of the P2X2
receptor controlled by alternative splicing. FEBS Lett 404:294298[CrossRef][Medline]
-
Simon J, Kidd EJ, Smith FM, Chessell IP,
Murrel-Lagnado R, Humphry PPA, Barnard EA 1997 Localization and
functional expression of splice variants of the
P2X2 receptor. Mol Pharmacol 52:237248[Abstract/Free Full Text]
-
Rassendren F, Buell GN, Virginio C, Collo G,
North A, Surprenant A 1997 The permeabilizing ATP receptor,
P2X7. J Biol Chem 272:54825486[Abstract/Free Full Text]
-
Nuttle LC, Dubyak GR 1994 Differential
activation of cation channels and non-selective pores by macrophage
P2Xz purinergic receptors expressed in Xenopus oocytes. J Biol
Chem 269:1398813996[Abstract/Free Full Text]
This article has been cited by other articles:

|
 |

|
 |
 
H. W. Zemkova, I. Bjelobaba, M. Tomic, H. Zemkova, and S. S. Stojilkovic
Molecular, pharmacological and functional properties of GABAA receptors in anterior pituitary cells
J. Physiol.,
July 1, 2008;
586(13):
3097 - 3111.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. E. Gonzalez-Iglesias, T. Murano, S. Li, M. Tomic, and S. S. Stojilkovic
Dopamine Inhibits Basal Prolactin Release in Pituitary Lactotrophs through Pertussis Toxin-Sensitive and -Insensitive Signaling Pathways
Endocrinology,
April 1, 2008;
149(4):
1470 - 1479.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Tsaneva-Atanasova, A. Sherman, F. van Goor, and S. S. Stojilkovic
Mechanism of Spontaneous and Receptor-Controlled Electrical Activity in Pituitary Somatotrophs: Experiments and Theory
J Neurophysiol,
July 1, 2007;
98(1):
131 - 144.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Zemkova, A. Balik, Y. Jiang, K. Kretschmannova, and S. S. Stojilkovic
Roles of Purinergic P2X Receptors as Pacemaking Channels and Modulators of Calcium-Mobilizing Pathway in Pituitary Gonadotrophs
Mol. Endocrinol.,
June 1, 2006;
20(6):
1423 - 1436.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. Andric, D. Zivadinovic, A. E. Gonzalez-Iglesias, A. Lachowicz, M. Tomic, and S. S. Stojilkovic
Endothelin-induced, Long Lasting, and Ca2+ Influx-independent Blockade of Intrinsic Secretion in Pituitary Cells by Gz Subunits
J. Biol. Chem.,
July 22, 2005;
280(29):
26896 - 26903.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-L. He, A. E. Gonzalez-Iglesias, and S. S. Stojilkovic
Role of Nucleotide P2 Receptors in Calcium Signaling and Prolactin Release in Pituitary Lactotrophs
J. Biol. Chem.,
November 21, 2003;
278(47):
46270 - 46277.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-L. He, H. Zemkova, T.-a. Koshimizu, M. Tomic, and S. S. Stojilkovic
Intracellular calcium measurements as a method in studies on activity of purinergic P2X receptor channels
Am J Physiol Cell Physiol,
August 1, 2003;
285(2):
C467 - C479.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. Andric, A. E. Gonzalez-Iglesias, F. Van Goor, M. Tomic, and S. S. Stojilkovic
Nitric Oxide Inhibits Prolactin Secretion in Pituitary Cells Downstream of Voltage-Gated Calcium Influx
Endocrinology,
July 1, 2003;
144(7):
2912 - 2921.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T.-a. Koshimizu, S. Ueno, A. Tanoue, N. Yanagihara, S. S. Stojilkovic, and G. Tsujimoto
Heteromultimerization Modulates P2X Receptor Functions through Participating Extracellular and C-terminal Subdomains
J. Biol. Chem.,
November 27, 2002;
277(49):
46891 - 46899.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Aga, C. J. Johnson, A. P. Hart, A. G. Guadarrama, M. Suresh, J. Svaren, P. J. Bertics, and B. J. Darien
Modulation of monocyte signaling and pore formation in response to agonists of the nucleotide receptor P2X7
J. Leukoc. Biol.,
July 1, 2002;
72(1):
222 - 232.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Tomic', F. Van Goor, M.-L. He, D. Zivadinovic, and S. S. Stojilkovic
Ca2+-Mobilizing Endothelin-A Receptors Inhibit Voltage-Gated Ca2+ Influx through Gi/o Signaling Pathway in Pituitary Lactotrophs
Mol. Pharmacol.,
June 1, 2002;
61(6):
1329 - 1339.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. S. Kostic, M. Tomic', S. A. Andric, and S. S. Stojilkovic
Calcium-independent and cAMP-dependent Modulation of Soluble Guanylyl Cyclase Activity by G Protein-coupled Receptors in Pituitary Cells
J. Biol. Chem.,
May 3, 2002;
277(19):
16412 - 16418.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Zivadinovic, M. Tomic, D. Yuan, and S. S. Stojilkovic
Cell-Type Specific Messenger Functions of Extracellular Calcium in the Anterior Pituitary
Endocrinology,
February 1, 2002;
143(2):
445 - 455.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Van Goor, Y.-X. Li, and S. S. Stojilkovic
Paradoxical Role of Large-Conductance Calcium-Activated K+ (BK) Channels in Controlling Action Potential-Driven Ca2+ Entry in Anterior Pituitary Cells
J. Neurosci.,
August 15, 2001;
21(16):
5902 - 5915.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Van Goor, D. Zivadinovic, and S. S. Stojilkovic
Differential Expression of Ionic Channels in Rat Anterior Pituitary Cells
Mol. Endocrinol.,
July 1, 2001;
15(7):
1222 - 1236.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Van Goor, D. Zivadinovic, A. J. Martinez-Fuentes, and S. S. Stojilkovic
Dependence of Pituitary Hormone Secretion on the Pattern of Spontaneus Voltage-gated Calcium Influx. CELL TYPE-SPECIFIC ACTION POTENTIAL SECRETION COUPLING
J. Biol. Chem.,
August 31, 2001;
276(36):
33840 - 33846.
[Abstract]
[Full Text]
[PDF]
|
 |
|